Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines. 2015

Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.

Histone deacetylase (HDAC)‑mediated epigenetic modification plays crucial roles in numerous biological processes, including cell cycle regulation, cell proliferation and apoptosis. HDAC inhibitors demonstrate antitumor effects in various cancers, including glioblastoma and breast cancer. HDAC inhibitors are therefore promising antitumor drugs for these tumors. The tumorigenesis and development of esophageal squamous cell carcinoma (ESCC) involve genetic and epigenetic mechanisms. However, the effects of the HDAC inhibitor on ESCC are not fully investigated. In the present study, ESCC cells were treated with trichostatin A (TSA) and its antitumor effects and related mechanisms were investigated. The results indicated that TSA suppressed the proliferation of ESCCs and caused G1 phase arrest by inducing the expression of p21 and p27. TSA also induced cell apoptosis by enhancing the expression of pro‑apoptotic protein Bax and decreasing the expression of anti‑apoptotic protein Bcl‑2. Furthermore, TSA inhibited the expression of phosphatidylinositol‑3‑kinase (PI3K) and reduced the phosphorylation of Akt and extracellular signal‑regulated kinase (ERK)1/2 in EC9706 and EC1 cell lines. High levels of acetylated histone H4 were detected in TSA‑treated ESCC cell lines. Overall, these results indicate that TSA suppresses ESCC cell growth by inhibiting the activation of the PI3K/Akt and ERK1/2 pathways. TSA also promotes cell apoptosis through epigenetic regulation of the expression of apoptosis‑related protein.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000077277 Esophageal Squamous Cell Carcinoma A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer. Oesophageal Squamous Cell Carcinoma
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
April 2013, Anticancer research,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
January 2020, Anti-cancer agents in medicinal chemistry,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
June 2010, Leukemia research,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
April 2014, Journal of cellular and molecular medicine,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
January 2009, European journal of gynaecological oncology,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
July 2015, Molecular medicine reports,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
January 2016, International journal of biological sciences,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
December 2005, Journal of neurosurgery,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
December 2007, Chinese medical journal,
Junfen Ma, and Xiaobing Guo, and Shijie Zhang, and Hongchun Liu, and Jing Lu, and Ziming Dong, and Kangdong Liu, and Liang Ming
January 2014, The Plant cell,
Copied contents to your clipboard!